Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Live imaging helps us understand skin immune responses and develop treatments.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

More research is needed to understand and manage rheumatoid arthritis better.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

Histone modification is key in treating chronic inflammatory skin diseases.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Fzd2 is important for skin and hair development through various signaling ways.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.